CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a coronavirus vaccine, in …
Read More »CanSino COVID-19 Vaccine Candidate Approved for Military Use in China
FILE PHOTO: This illustration, taken on April 10, 2020, shows small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe. REUTERS / Dado Ruvic / File Photo BEIJING (Reuters) – China’s military has been given the green light to use a COVID-19 candidate vaccine developed by its research …
Read More »CanSino COVID-19 Vaccine Candidate Approved for Military Use in China
FILE PHOTO: This illustration, taken on April 10, 2020, shows small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe. REUTERS / Dado Ruvic / File Photo BEIJING (Reuters) – China’s military has been given the green light to use a COVID-19 candidate vaccine developed by its research …
Read More »Moderna targets third quarter for first doses of possible COVID-19 vaccine with Catalent deal
(Reuters) – Moderna Inc (MRNA.O) said Thursday that it was partnering with contract pharmacist Catalent Inc (CTLT.N) to prepare 100 million initial doses of its coronavirus vaccine for the United States, starting in the third quarter of this year. FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which …
Read More »Gilead’s remdesivir to become Europe’s first COVID-19 therapy
(Reuters) – Doctors in Europe will soon be able to treat COVID-19 patients with Gilead (GILD.O), antiviral drug, remdesivir, after the support of the health regulator set it on the path to becoming the first therapy for the disease on the continent. FILE PHOTO: Pharmaceutical company Gilead Sciences Inc is …
Read More »